The DOJ has initiated nearly 70 enforcement actions in 2025, focusing on diagnostics, DME, and telehealth fraud. Significant fraudulent claims against Medicare are being addressed, resulting in severe penalties for involved individuals.
Former top HHS attorney Rob DeConti said the areas remain targets of focus because they are highly lucrative and offer a relatively low barrier to entry.
The largest single case involved DMERx, an online service that facilitated more than $1bn in unnecessary DME prescriptions.

DME And Diagnostics In Crosshairs As DOJ ‘Follows The Money’

More from Legal & IP